Vavrušáková · Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2025 · narrative review · n=?

From traditional Chinese medicine to molecular oncology - pleiotropic effects of tauroursodeoxycholic acid.

Cited 2 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Narrative review summarizing existing literature without primary empirical data or systematic synthesis

PubMed 40962506 · doi:10.48095/ccko2025270 · record verified 2026-08-29

What was done

The authors synthesized literature on the biological properties and therapeutic potential of tauroursodeoxycholic acid (TUDCA), a hydrophilic secondary bile acid, across hepatobiliary and extrahepatic clinical domains.

What was found

The abstract provides no numerical findings, effect sizes, or statistical metrics. It qualitatively notes that TUDCA demonstrates multifunctional properties with potential utility in oncology, neurodegenerative conditions, cardiovascular disease, gastrointestinal dysfunction, and glucose metabolism disorders.

Why it matters

This review highlights the expanding interest in repurposing TUDCA beyond traditional hepatology indications toward systemic and oncological applications.

Limits

The abstract describes a narrative overview without detailing search methodology, inclusion criteria, or risk of bias assessments. No primary human clinical trial data or quantitative results are reported.

Cited by